Do analysts prefer LAZ or HQH?

Lazard presently has a consensus target price of $50.38, indicating a potential upside of 22.43%. Given Lazard's stronger consensus rating and higher possible upside, equities research analysts clearly believe Lazard is more favorable than abrdn Healthcare Investors. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lazard 3 Sell rating(s) 4 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.09 abrdn Healthcare Investors 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable earnings and valuation, LAZ or HQH?

Lazard has higher revenue and earnings than abrdn Healthcare Investors. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lazard $3.10B 1.47 $236.83M $2.04 20.17 abrdn Healthcare Investors N/A N/A N/A N/A N/A

Does the media refer more to LAZ or HQH?

In the previous week, Lazard had 10 more articles in the media than abrdn Healthcare Investors. MarketBeat recorded 12 mentions for Lazard and 2 mentions for abrdn Healthcare Investors. abrdn Healthcare Investors' average media sentiment score of 0.50 beat Lazard's score of 0.48 indicating that abrdn Healthcare Investors is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lazard 4 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral abrdn Healthcare Investors 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer HQH or PJT?

PJT Partners has a consensus target price of $177.50, indicating a potential upside of 8.41%. Given PJT Partners' stronger consensus rating and higher probable upside, analysts clearly believe PJT Partners is more favorable than abrdn Healthcare Investors. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score abrdn Healthcare Investors 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 PJT Partners 1 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.29

Which has better earnings & valuation, HQH or PJT?

PJT Partners has higher revenue and earnings than abrdn Healthcare Investors. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio abrdn Healthcare Investors N/A N/A N/A N/A N/A PJT Partners $1.71B 2.44 $180.12M $7.31 22.40

Does the media prefer HQH or PJT?

In the previous week, PJT Partners had 2 more articles in the media than abrdn Healthcare Investors. MarketBeat recorded 4 mentions for PJT Partners and 2 mentions for abrdn Healthcare Investors. PJT Partners' average media sentiment score of 1.30 beat abrdn Healthcare Investors' score of 0.50 indicating that PJT Partners is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment abrdn Healthcare Investors 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PJT Partners 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend HQH or FHI?

Federated Hermes has a consensus target price of $57.40, suggesting a potential downside of 3.76%. Given Federated Hermes' stronger consensus rating and higher probable upside, analysts plainly believe Federated Hermes is more favorable than abrdn Healthcare Investors. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score abrdn Healthcare Investors 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Federated Hermes 1 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 2.50

Which has stronger valuation & earnings, HQH or FHI?

Federated Hermes has higher revenue and earnings than abrdn Healthcare Investors. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio abrdn Healthcare Investors N/A N/A N/A N/A N/A Federated Hermes $1.80B 2.47 $403.30M $5.38 11.09

Does the media refer more to HQH or FHI?

In the previous week, Federated Hermes had 6 more articles in the media than abrdn Healthcare Investors. MarketBeat recorded 8 mentions for Federated Hermes and 2 mentions for abrdn Healthcare Investors. Federated Hermes' average media sentiment score of 0.76 beat abrdn Healthcare Investors' score of 0.50 indicating that Federated Hermes is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment abrdn Healthcare Investors 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Federated Hermes 3 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate HQH or MIAX?

Miami International has a consensus price target of $51.40, indicating a potential upside of 23.70%. Given Miami International's stronger consensus rating and higher probable upside, analysts clearly believe Miami International is more favorable than abrdn Healthcare Investors. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score abrdn Healthcare Investors 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Miami International 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.29

Which has stronger earnings and valuation, HQH or MIAX?

abrdn Healthcare Investors has higher earnings, but lower revenue than Miami International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio abrdn Healthcare Investors N/A N/A N/A N/A N/A Miami International $1.36B 3.02 -$70.03M $0.77 53.96

Does the media prefer HQH or MIAX?

In the previous week, Miami International had 5 more articles in the media than abrdn Healthcare Investors. MarketBeat recorded 7 mentions for Miami International and 2 mentions for abrdn Healthcare Investors. Miami International's average media sentiment score of 0.56 beat abrdn Healthcare Investors' score of 0.50 indicating that Miami International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment abrdn Healthcare Investors 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Miami International 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend CNS or HQH?

Cohen & Steers currently has a consensus target price of $78.00, suggesting a potential upside of 3.93%. Given Cohen & Steers' stronger consensus rating and higher possible upside, research analysts clearly believe Cohen & Steers is more favorable than abrdn Healthcare Investors. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cohen & Steers 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 abrdn Healthcare Investors 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable valuation and earnings, CNS or HQH?

Cohen & Steers has higher revenue and earnings than abrdn Healthcare Investors. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cohen & Steers $556.12M 6.94 $153.22M $3.26 23.02 abrdn Healthcare Investors N/A N/A N/A N/A N/A

Does the media favor CNS or HQH?

In the previous week, Cohen & Steers had 2 more articles in the media than abrdn Healthcare Investors. MarketBeat recorded 4 mentions for Cohen & Steers and 2 mentions for abrdn Healthcare Investors. Cohen & Steers' average media sentiment score of 1.04 beat abrdn Healthcare Investors' score of 0.50 indicating that Cohen & Steers is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cohen & Steers 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive abrdn Healthcare Investors 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

abrdn Healthcare Investors (HQH) Competitors

$21.79 +0.04 (+0.17%)

Closing price 09/11/2026 03:58 PM Eastern

Extended Trading

$21.74 -0.04 (-0.19%)

As of 09/11/2026 07:48 PM Eastern

Compare

HQH vs. LAZ, PJT, FHI, MIAX, and CNS

Should you buy abrdn Healthcare Investors stock or one of its competitors? abrdn Healthcare Investors's main competitors and comparable companies include Lazard (LAZ), PJT Partners (PJT), Federated Hermes (FHI), Miami International (MIAX), and Cohen & Steers (CNS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "capital markets" industry.

How does abrdn Healthcare Investors compare to Lazard?

Lazard (NYSE:LAZ) and abrdn Healthcare Investors (NYSE:HQH) are both finance companies, but which is the better investment? We will compare the two companies based on the strength of their risk, media sentiment, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Lazard has a net margin of 6.95% compared to abrdn Healthcare Investors' net margin of 0.00%. Lazard's return on equity of 23.58% beat abrdn Healthcare Investors' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lazard	6.95%	23.58%	4.63%
abrdn Healthcare Investors	N/A	N/A	N/A

Lazard has higher revenue and earnings than abrdn Healthcare Investors.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lazard	$3.10B	1.47	$236.83M	$2.04	20.17
abrdn Healthcare Investors	N/A	N/A	N/A	N/A	N/A

Lazard presently has a consensus target price of $50.38, indicating a potential upside of 22.43%. Given Lazard's stronger consensus rating and higher possible upside, equities research analysts clearly believe Lazard is more favorable than abrdn Healthcare Investors.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lazard	3 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.09
abrdn Healthcare Investors	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Lazard had 10 more articles in the media than abrdn Healthcare Investors. MarketBeat recorded 12 mentions for Lazard and 2 mentions for abrdn Healthcare Investors. abrdn Healthcare Investors' average media sentiment score of 0.50 beat Lazard's score of 0.48 indicating that abrdn Healthcare Investors is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lazard	4 Very Positive mention(s)	0 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
abrdn Healthcare Investors	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Lazard has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market. Comparatively, abrdn Healthcare Investors has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market.

Lazard pays an annual dividend of $2.00 per share and has a dividend yield of 4.9%. abrdn Healthcare Investors pays an annual dividend of $2.47 per share and has a dividend yield of 11.3%. Lazard pays out 98.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

54.8% of Lazard shares are owned by institutional investors. Comparatively, 32.6% of abrdn Healthcare Investors shares are owned by institutional investors. 1.0% of Lazard shares are owned by company insiders. Comparatively, 7.3% of abrdn Healthcare Investors shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Lazard beats abrdn Healthcare Investors on 10 of the 14 factors compared between the two stocks.

How does abrdn Healthcare Investors compare to PJT Partners?

abrdn Healthcare Investors (NYSE:HQH) and PJT Partners (NYSE:PJT) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

32.6% of abrdn Healthcare Investors shares are held by institutional investors. Comparatively, 89.2% of PJT Partners shares are held by institutional investors. 7.3% of abrdn Healthcare Investors shares are held by insiders. Comparatively, 11.0% of PJT Partners shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

abrdn Healthcare Investors pays an annual dividend of $2.47 per share and has a dividend yield of 11.3%. PJT Partners pays an annual dividend of $1.00 per share and has a dividend yield of 0.6%. PJT Partners pays out 13.7% of its earnings in the form of a dividend.

In the previous week, PJT Partners had 2 more articles in the media than abrdn Healthcare Investors. MarketBeat recorded 4 mentions for PJT Partners and 2 mentions for abrdn Healthcare Investors. PJT Partners' average media sentiment score of 1.30 beat abrdn Healthcare Investors' score of 0.50 indicating that PJT Partners is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
abrdn Healthcare Investors	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PJT Partners	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

PJT Partners has a consensus target price of $177.50, indicating a potential upside of 8.41%. Given PJT Partners' stronger consensus rating and higher probable upside, analysts clearly believe PJT Partners is more favorable than abrdn Healthcare Investors.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
abrdn Healthcare Investors	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
PJT Partners	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29

PJT Partners has higher revenue and earnings than abrdn Healthcare Investors.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
abrdn Healthcare Investors	N/A	N/A	N/A	N/A	N/A
PJT Partners	$1.71B	2.44	$180.12M	$7.31	22.40

abrdn Healthcare Investors has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market. Comparatively, PJT Partners has a beta of 0.84, meaning that its stock price is 16% less volatile than the broader market.

PJT Partners has a net margin of 10.57% compared to abrdn Healthcare Investors' net margin of 0.00%. PJT Partners' return on equity of 32.66% beat abrdn Healthcare Investors' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
abrdn Healthcare Investors	N/A	N/A	N/A
PJT Partners	10.57%	32.66%	18.28%

Summary

PJT Partners beats abrdn Healthcare Investors on 12 of the 14 factors compared between the two stocks.

How does abrdn Healthcare Investors compare to Federated Hermes?

abrdn Healthcare Investors (NYSE:HQH) and Federated Hermes (NYSE:FHI) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends, profitability and media sentiment.

Federated Hermes has higher revenue and earnings than abrdn Healthcare Investors.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
abrdn Healthcare Investors	N/A	N/A	N/A	N/A	N/A
Federated Hermes	$1.80B	2.47	$403.30M	$5.38	11.09

abrdn Healthcare Investors has a beta of 0.78, indicating that its share price is 22% less volatile than the broader market. Comparatively, Federated Hermes has a beta of 0.65, indicating that its share price is 35% less volatile than the broader market.

Federated Hermes has a net margin of 21.30% compared to abrdn Healthcare Investors' net margin of 0.00%. Federated Hermes' return on equity of 34.03% beat abrdn Healthcare Investors' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
abrdn Healthcare Investors	N/A	N/A	N/A
Federated Hermes	21.30%	34.03%	18.54%

Federated Hermes has a consensus target price of $57.40, suggesting a potential downside of 3.76%. Given Federated Hermes' stronger consensus rating and higher probable upside, analysts plainly believe Federated Hermes is more favorable than abrdn Healthcare Investors.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
abrdn Healthcare Investors	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Federated Hermes	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	2.50

In the previous week, Federated Hermes had 6 more articles in the media than abrdn Healthcare Investors. MarketBeat recorded 8 mentions for Federated Hermes and 2 mentions for abrdn Healthcare Investors. Federated Hermes' average media sentiment score of 0.76 beat abrdn Healthcare Investors' score of 0.50 indicating that Federated Hermes is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
abrdn Healthcare Investors	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Federated Hermes	3 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

32.6% of abrdn Healthcare Investors shares are held by institutional investors. Comparatively, 75.9% of Federated Hermes shares are held by institutional investors. 7.3% of abrdn Healthcare Investors shares are held by insiders. Comparatively, 4.2% of Federated Hermes shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

abrdn Healthcare Investors pays an annual dividend of $2.47 per share and has a dividend yield of 11.3%. Federated Hermes pays an annual dividend of $1.52 per share and has a dividend yield of 2.5%. Federated Hermes pays out 28.3% of its earnings in the form of a dividend. Federated Hermes has increased its dividend for 4 consecutive years.

Summary

Federated Hermes beats abrdn Healthcare Investors on 12 of the 16 factors compared between the two stocks.

How does abrdn Healthcare Investors compare to Miami International?

abrdn Healthcare Investors (NYSE:HQH) and Miami International (NYSE:MIAX) are both finance companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, media sentiment, earnings and institutional ownership.

32.6% of abrdn Healthcare Investors shares are owned by institutional investors. 7.3% of abrdn Healthcare Investors shares are owned by insiders. Comparatively, 15.6% of Miami International shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Miami International has a consensus price target of $51.40, indicating a potential upside of 23.70%. Given Miami International's stronger consensus rating and higher probable upside, analysts clearly believe Miami International is more favorable than abrdn Healthcare Investors.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
abrdn Healthcare Investors	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Miami International	0 Sell rating(s)	5 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.29

Miami International has a net margin of 9.70% compared to abrdn Healthcare Investors' net margin of 0.00%. Miami International's return on equity of 16.95% beat abrdn Healthcare Investors' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
abrdn Healthcare Investors	N/A	N/A	N/A
Miami International	9.70%	16.95%	12.05%

In the previous week, Miami International had 5 more articles in the media than abrdn Healthcare Investors. MarketBeat recorded 7 mentions for Miami International and 2 mentions for abrdn Healthcare Investors. Miami International's average media sentiment score of 0.56 beat abrdn Healthcare Investors' score of 0.50 indicating that Miami International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
abrdn Healthcare Investors	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Miami International	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

abrdn Healthcare Investors has higher earnings, but lower revenue than Miami International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
abrdn Healthcare Investors	N/A	N/A	N/A	N/A	N/A
Miami International	$1.36B	3.02	-$70.03M	$0.77	53.96

Summary

Miami International beats abrdn Healthcare Investors on 10 of the 11 factors compared between the two stocks.

How does abrdn Healthcare Investors compare to Cohen & Steers?

Cohen & Steers (NYSE:CNS) and abrdn Healthcare Investors (NYSE:HQH) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, risk and valuation.

Cohen & Steers has higher revenue and earnings than abrdn Healthcare Investors.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cohen & Steers	$556.12M	6.94	$153.22M	$3.26	23.02
abrdn Healthcare Investors	N/A	N/A	N/A	N/A	N/A

Cohen & Steers has a beta of 1.21, suggesting that its share price is 21% more volatile than the broader market. Comparatively, abrdn Healthcare Investors has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market.

Cohen & Steers pays an annual dividend of $2.68 per share and has a dividend yield of 3.6%. abrdn Healthcare Investors pays an annual dividend of $2.47 per share and has a dividend yield of 11.3%. Cohen & Steers pays out 82.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cohen & Steers has raised its dividend for 16 consecutive years.

Cohen & Steers currently has a consensus target price of $78.00, suggesting a potential upside of 3.93%. Given Cohen & Steers' stronger consensus rating and higher possible upside, research analysts clearly believe Cohen & Steers is more favorable than abrdn Healthcare Investors.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cohen & Steers	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
abrdn Healthcare Investors	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

51.5% of Cohen & Steers shares are held by institutional investors. Comparatively, 32.6% of abrdn Healthcare Investors shares are held by institutional investors. 45.4% of Cohen & Steers shares are held by company insiders. Comparatively, 7.3% of abrdn Healthcare Investors shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Cohen & Steers has a net margin of 28.82% compared to abrdn Healthcare Investors' net margin of 0.00%. Cohen & Steers' return on equity of 27.41% beat abrdn Healthcare Investors' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cohen & Steers	28.82%	27.41%	19.58%
abrdn Healthcare Investors	N/A	N/A	N/A

In the previous week, Cohen & Steers had 2 more articles in the media than abrdn Healthcare Investors. MarketBeat recorded 4 mentions for Cohen & Steers and 2 mentions for abrdn Healthcare Investors. Cohen & Steers' average media sentiment score of 1.04 beat abrdn Healthcare Investors' score of 0.50 indicating that Cohen & Steers is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cohen & Steers	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
abrdn Healthcare Investors	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Cohen & Steers beats abrdn Healthcare Investors on 13 of the 15 factors compared between the two stocks.

Get abrdn Healthcare Investors News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HQH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HQH vs. The Competition

Export

Metric	abrdn Healthcare Investors	Capital Markets Industry	Finance Sector	NYSE Exchange
Market Cap	$1.24B	$5.52B	$13.80B	$23.39B
Dividend Yield	11.35%	7.47%	5.94%	3.56%
P/E Ratio	N/A	28.70	23.91	24.75
Price / Sales	N/A	1,232.66	509.48	21.22
Price / Cash	N/A	47.92	40.45	34.17
Price / Book	N/A	3.53	2.75	4.74
Net Income	N/A	$418.04M	$1.32B	$1.07B
7 Day Performance	-3.43%	-1.39%	-1.17%	-2.00%
1 Month Performance	-7.14%	-1.45%	0.25%	-2.69%
1 Year Performance	30.57%	4.83%	9.27%	10.45%

abrdn Healthcare Investors Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HQH abrdn Healthcare Investors	N/A	$21.79 +0.2%	N/A	+29.4%	$1.24B	N/A	N/A	147,000	News Coverage Short Interest Decrease
LAZ Lazard	4.3748 of 5 stars	$43.98 -2.3%	$50.38 +14.5%	-27.5%	$4.97B	$3.10B	21.56	3,309	Gap Down
PJT PJT Partners	4.0184 of 5 stars	$181.70 -0.6%	$177.50 -2.3%	-12.4%	$4.67B	$1.71B	24.86	1,224	Positive News
FHI Federated Hermes	2.7991 of 5 stars	$61.52 -1.4%	$57.40 -6.7%	+10.3%	$4.66B	$1.93B	11.44	2,091	News Coverage Analyst Upgrade
MIAX Miami International	3.6353 of 5 stars	$43.41 +2.4%	$51.40 +18.4%	+11.1%	$4.21B	$1.47B	56.38	433

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:HQH) was last updated on 9/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

abrdn Healthcare Investors (HQH) Competitors

HQH vs. LAZ, PJT, FHI, MIAX, and CNS

How does abrdn Healthcare Investors compare to Lazard?

Summary

How does abrdn Healthcare Investors compare to PJT Partners?

Summary

How does abrdn Healthcare Investors compare to Federated Hermes?

Summary

How does abrdn Healthcare Investors compare to Miami International?

Summary

How does abrdn Healthcare Investors compare to Cohen & Steers?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQH vs. The Competition

abrdn Healthcare Investors Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

abrdn Healthcare Investors (HQH) Competitors

HQH vs. LAZ, PJT, FHI, MIAX, and CNS

How does abrdn Healthcare Investors compare to Lazard?

Is LAZ or HQH more profitable?

Which has preferable earnings and valuation, LAZ or HQH?

Do analysts prefer LAZ or HQH?

Does the media refer more to LAZ or HQH?

Which has more volatility and risk, LAZ or HQH?

Is LAZ or HQH a better dividend stock?

Do institutionals & insiders have more ownership in LAZ or HQH?

Summary

How does abrdn Healthcare Investors compare to PJT Partners?

Do institutionals and insiders hold more shares of HQH or PJT?

Is HQH or PJT a better dividend stock?

Does the media prefer HQH or PJT?

Do analysts prefer HQH or PJT?

Which has better earnings & valuation, HQH or PJT?

Which has more volatility & risk, HQH or PJT?

Is HQH or PJT more profitable?

Summary

How does abrdn Healthcare Investors compare to Federated Hermes?

Which has stronger valuation & earnings, HQH or FHI?

Which has more volatility & risk, HQH or FHI?

Is HQH or FHI more profitable?

Do analysts recommend HQH or FHI?

Does the media refer more to HQH or FHI?

Do insiders & institutionals believe in HQH or FHI?

Is HQH or FHI a better dividend stock?

Summary

How does abrdn Healthcare Investors compare to Miami International?

Do insiders & institutionals have more ownership in HQH or MIAX?

Do analysts rate HQH or MIAX?

Is HQH or MIAX more profitable?

Does the media prefer HQH or MIAX?

Which has stronger earnings and valuation, HQH or MIAX?

Summary

How does abrdn Healthcare Investors compare to Cohen & Steers?

Which has preferable valuation and earnings, CNS or HQH?

Which has more risk & volatility, CNS or HQH?

Is CNS or HQH a better dividend stock?

Do analysts recommend CNS or HQH?

Do insiders & institutionals have more ownership in CNS or HQH?

Is CNS or HQH more profitable?

Does the media favor CNS or HQH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQH vs. The Competition

abrdn Healthcare Investors Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools